24 episodes

Interviews with clinical experts, discussing key issues in rheumatology.

Medicine Matters rheumatology Springer Healthcare

    • Health & Fitness

Interviews with clinical experts, discussing key issues in rheumatology.

    Repurposing rheumatology drugs for COVID-19: TNF inhibitors

    Repurposing rheumatology drugs for COVID-19: TNF inhibitors

    Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

    • 16 min
    Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

    Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

    Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    • 19 min
    Repurposing rheumatology drugs for COVID-19: JAK inhibitors

    Repurposing rheumatology drugs for COVID-19: JAK inhibitors

    Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

    • 10 min
    Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

    Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine (with Alfred Kim)

    In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
    In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.
    Find more on Medicine Matters rheumatology

    • 16 min
    Repurposing rheumatology drugs for COVID-19: What do we know? (with Jinoos Yazdany)

    Repurposing rheumatology drugs for COVID-19: What do we know? (with Jinoos Yazdany)

    In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
    For the introductory podcast, Jinoos Yazdany, rheumatologist and Professor of Medicine at the University of California, San Francisco in the USA, talks about the rationale behind investigating these agents and the role of rheumatologists in ensuring they are studied as safely and efficiently as possible.
    Find more on Medicine Matters rheumatology

    • 13 min
    A closer look at the ACR guidance on COVID-19 and rheumatology care (with Ted Mikuls)

    A closer look at the ACR guidance on COVID-19 and rheumatology care (with Ted Mikuls)

    In April 2020, the American College of Rheumatology issued guidance for the management of people with rheumatic diseases during the COVID-19 pandemic.
    We spoke to lead author Ted Mikuls, from the University of Nebraska Medical Center in the USA, to find out more about what rheumatologists should do to best care for their patients in light of COVID-19, and what some of the unanswered questions are.
    Find more on Medicine Matters rheumatology
    Image credit: COVID-19 illustration © koto_feja/Getty Images/iStock

    • 8 min

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
Maintenance Phase
Aubrey Gordon & Michael Hobbes
The School of Greatness
Lewis Howes
Nothing much happens: bedtime stories to help you sleep
iHeartPodcasts
The Dr. John Delony Show
Ramsey Network
Ten Percent Happier with Dan Harris
Ten Percent Happier